5y11 - Revision history

OCA at 07:03, 14 October 2020

OCA — Wed, 14 Oct 2020 07:03:23 GMT

←Older revision		Revision as of 07:03, 14 October 2020
Line 1:		Line 1:

	==SFTSV GN with neutralizing antibody MAb4-5==		==SFTSV GN with neutralizing antibody MAb4-5==
-	<StructureSection load='5y11' size='340' side='right' caption='[[5y11]], [[Resolution\|resolution]] 2.10Å' scene=''>	+	<StructureSection load='5y11' size='340' side='right'caption='[[5y11]], [[Resolution\|resolution]] 2.10Å' scene=''>
	== Structural highlights ==		== Structural highlights ==
-	<table><tr><td colspan='2'>[[5y11]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Y11 OCA]. For a <b>guided tour on the structure components</b> use [http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5Y11 FirstGlance]. <br>	+	<table><tr><td colspan='2'>[[5y11]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human] and [http://en.wikipedia.org/wiki/Sfts_bunyavirus Sfts bunyavirus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Y11 OCA]. For a <b>guided tour on the structure components</b> use [http://proteopedia.org/fgij/fg.htm?mol=5Y11 FirstGlance]. <br>
-	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>	+	</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
-	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://~~oca~~.~~weizmann.ac.il/oca-docs~~/fgij/fg.htm?mol=5y11 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5y11 OCA], [http://pdbe.org/5y11 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5y11 RCSB], [http://www.ebi.ac.uk/pdbsum/5y11 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5y11 ProSAT]</span></td></tr>	+	<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://proteopedia.org/fgij/fg.htm?mol=5y11 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5y11 OCA], [http://pdbe.org/5y11 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5y11 RCSB], [http://www.ebi.ac.uk/pdbsum/5y11 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5y11 ProSAT]</span></td></tr>
	</table>		</table>
	<div style="background-color:#fffaf0;">		<div style="background-color:#fffaf0;">
Line 20:		Line 20:
	__TOC__		__TOC__
	</StructureSection>		</StructureSection>
		+	[[Category: Human]]
		+	[[Category: Large Structures]]
		+	[[Category: Sfts bunyavirus]]
	[[Category: Chai, Y]]		[[Category: Chai, Y]]
	[[Category: Gao, F]]		[[Category: Gao, F]]

OCA: Protected "5y11" [edit=sysop:move=sysop]

OCA — Wed, 13 Sep 2017 10:35:22 GMT

Protected "5y11" [edit=sysop:move=sysop]

←Older revision

Revision as of 10:35, 13 September 2017

OCA: New page: ==SFTSV GN with neutralizing antibody MAb4-5== == Structural high...

OCA — Wed, 13 Sep 2017 10:35:20 GMT

New page: ==SFTSV GN with neutralizing antibody MAb4-5== <StructureSection load='5y11' size='340' side='right' caption='5y11, resolution 2.10Å' scene=''> == Structural high...

New page

==SFTSV GN with neutralizing antibody MAb4-5==
<StructureSection load='5y11' size='340' side='right' caption='[[5y11]], [[Resolution|resolution]] 2.10Å' scene=''>
== Structural highlights ==
<table><tr><td colspan='2'>[[5y11]] is a 3 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5Y11 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5Y11 FirstGlance]. <br>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=MAN:ALPHA-D-MANNOSE'>MAN</scene>, <scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene></td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5y11 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5y11 OCA], [http://pdbe.org/5y11 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5y11 RCSB], [http://www.ebi.ac.uk/pdbsum/5y11 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5y11 ProSAT]</span></td></tr>
</table>
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
Severe fever with thrombocytopenia syndrome virus (SFTSV) and Rift Valley fever virus (RVFV) are two arthropod-borne phleboviruses in the Bunyaviridae family, which cause severe illness in humans and animals. Glycoprotein N (Gn) is one of the envelope proteins on the virus surface and is a major antigenic component. Despite its importance for virus entry and fusion, the molecular features of the phleboviruse Gn were unknown. Here, we present the crystal structures of the Gn head domain from both SFTSV and RVFV, which display a similar compact triangular shape overall, while the three subdomains (domains I, II, and III) making up the Gn head display different arrangements. Ten cysteines in the Gn stem region are conserved among phleboviruses, four of which are responsible for Gn dimerization, as revealed in this study, and they are highly conserved for all members in Bunyaviridae Therefore, we propose an anchoring mode on the viral surface. The complex structure of the SFTSV Gn head and human neutralizing antibody MAb 4-5 reveals that helices alpha6 in subdomain III is the key component for neutralization. Importantly, the structure indicates that domain III is an ideal region recognized by specific neutralizing antibodies, while domain II is probably recognized by broadly neutralizing antibodies. Collectively, Gn is a desirable vaccine target, and our data provide a molecular basis for the rational design of vaccines against the diseases caused by phleboviruses and a model for bunyavirus Gn embedding on the viral surface.

Structures of phlebovirus glycoprotein Gn and identification of a neutralizing antibody epitope.,Wu Y, Zhu Y, Gao F, Jiao Y, Oladejo BO, Chai Y, Bi Y, Lu S, Dong M, Zhang C, Huang G, Wong G, Li N, Zhang Y, Li Y, Feng WH, Shi Y, Liang M, Zhang R, Qi J, Gao GF Proc Natl Acad Sci U S A. 2017 Sep 5;114(36):E7564-E7573. doi:, 10.1073/pnas.1705176114. Epub 2017 Aug 21. PMID:28827346<ref>PMID:28827346</ref>

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
</div>
<div class="pdbe-citations 5y11" style="background-color:#fffaf0;"></div>
== References ==
<references/>
__TOC__
</StructureSection>
[[Category: Chai, Y]]
[[Category: Gao, F]]
[[Category: Gao, G F]]
[[Category: Qi, J X]]
[[Category: Wu, Y]]
[[Category: Gn]]
[[Category: Immune system-viral system complex]]
[[Category: Neutralizing antibody]]
[[Category: Phlebovirus]]
[[Category: Sftsv]]
[[Category: Viral protein]]